Aspirin reduces the incidence of metastatic Braf mutant colorectal cancer in a preclinical trial

被引：0
|
作者：
Kane, A. [1 ,2 ,3 ]
Mckeone, D. [1 ]
Liu, C. [1 ,2 ]
Borowsky, J. [1 ,2 ,3 ]
Leggett, B. [1 ,2 ,4 ]
Whitehall, V. [1 ,2 ,3 ]
机构：
[1] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia
[2] Univ Queensland, Brisbane, Qld, Australia
[3] Pathol Queensland, Brisbane, Qld, Australia
[4] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
213
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [21] Analysis of medical practices for French patients with BRAF mutant metastatic colorectal cancer
    Mais, Laetitia
    Bourien, Heloise
    Aboudaram, Amelie
    Lievre, Astrid
    Dupuy, Marie
    Francois, Eric
    Artru, Pascal
    Senellart, Helene
    Coriat, Romain
    Edeline, Julien
    Guimbaud, Rosine
    Samalin, Emmanuelle
    Desseigne, Francoise
    Sarabi, Matthieu
    Ferlay, Pierre Guibertt Celine
    De la Fouchardiere, Christelle
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [22] Daily aspirin reduces colorectal cancer incidence in patients with Lynch syndrome
    Barton, Mary Kay
    CA-A CANCER JOURNAL FOR CLINICIANS, 2012, 62 (03) : 143 - 144
  • [23] Eruptive Melanocytic Nevi Secondary to Encorafenib for BRAF Mutant Metastatic Colorectal Cancer
    Meneguzzo, Alberto
    Lazzarotto, Annalisa
    Alaibac, Mauro
    IN VIVO, 2020, 34 (01): : 441 - 445
  • [24] Targeting mutant BRAF in colorectal cancer
    David Carroll
    R Carson
    S Van Schaeybroeck
    PG Johnston
    BMC Proceedings, 7 (Suppl 1)
  • [25] Survival determinants with matched targeted therapies in BRAF mutant metastatic colorectal cancer (mCRC).
    Sanz-Garcia, Enrique
    Martinez, Ana Maria
    Elez, Elena
    Argiles, Guillem
    Grasselli, Julieta
    Macarulla, Teresa
    Capdevila, Jaume
    Alsina, Maria
    Sauri, Tamara
    Hierro, Cinta
    Matos, Ignacio
    Verdaguer, Helena
    Azaro, Analia
    Landolfi, Stefania
    Hernandez-Losa, Javier
    Rodon, Jordi
    Nuciforo, Paolo
    Vivancos, Ana
    Dienstmann, Rodrigo
    Tabernero, Josep
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [26] Targeting BRAF mutant metastatic colorectal cancer: clinical implications and emerging therapeutic strategies
    Tie, Jeanne
    Desai, Jayesh
    TARGETED ONCOLOGY, 2015, 10 (02) : 179 - 188
  • [27] Real-world treatment and outcomes of patients with metastatic BRAF mutant colorectal cancer
    Xu, Ting
    Li, Jian
    Wang, Zhenghang
    Zhang, Xiaotian
    Zhou, Jun
    Lu, Zhihao
    Shen, Lin
    Wang, Xicheng
    CANCER MEDICINE, 2023, 12 (09): : 10473 - 10484
  • [28] Targeting BRAF mutant metastatic colorectal cancer: clinical implications and emerging therapeutic strategies
    Jeanne Tie
    Jayesh Desai
    Targeted Oncology, 2015, 10 : 179 - 188
  • [29] Review: Aspirin reduces colorectal cancer incidence and mortality in patients at average risk
    Chubak, J.
    Whitlock, E. P.
    Williams, S. B.
    ANNALS OF INTERNAL MEDICINE, 2016, 165 (04) : JC16 - JC16
  • [30] PLX4032 in metastatic colorectal cancer patients with mutant BRAF tumors.
    Kopetz, S.
    Desai, J.
    Chan, E.
    Hecht, J. R.
    O'Dwyer, P. J.
    Lee, R. J.
    Nolop, K. B.
    Saltz, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345